Dun & Bradstreet Holdings, Inc. (DNB)

Theseus Pharmaceuticals Revenue

Dun & Bradstreet Holdings had revenue of $579.80M in the quarter ending March 31, 2025, with 2.71% growth. This brings the company's revenue in the last twelve months to $2.40B, up 2.52% year-over-year. In the year 2024, Dun & Bradstreet Holdings had annual revenue of $2.38B with 2.93% growth.

• Revenue (ttm): $2.40B
• Revenue Growth: +2.52%
• P/S Ratio: 1.64
• Revenue / Employee: $383,704
• Employees: 6,247
• Market Cap: 4.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.38B	67.70M	2.93%
Dec 31, 2023	2.31B	89.40M	4.02%
Dec 31, 2022	2.22B	59.00M	2.72%
Dec 31, 2021	2.17B	426.90M	24.55%
Dec 31, 2020	1.74B	299.70M	20.83%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.